AI

aromatase inhibitor

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AI, covering 2019-04-10 to 2022-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score [Phase 2]